Buffalo Opioid Intervention Court

The first opioid-specific drug court of its kind in the United States that immediately links participants to medications for opioid use disorder

The Buffalo Opioid Intervention Court began in 2017 after several drug court participants experienced fatal overdoses within a single week. It is the first opioid-specific drug court in the United States.

Individuals that are arrested and qualify for the opioid court will be diverted at arraignment to be initiated on medication treatment (buprenorphine, methadone, or extended-release naltrexone depending on the preferences of the individual). Alternatively, the program also supports an abstinence-based pathway (no medication treatment). After being stabilized on medications, the participants are linked to ancillary services, which usually consists of 90 days of outpatient treatment with counseling along with linkage to social services. In addition, accountability is provided by both daily court appearances and urine drug screens. 

An overview of the Buffalo Opioid Intervention Court can be found here. More information about this special type of drug court can be found in the presentations here and here, the video here, and the news article here. More information on opioid intervention courts in general can be found here

This program is currently being independently evaluated. It has been replicated throughout New York State and the entire network of opioid courts is currently being evaluated. Preliminary evidence suggests that these types of courts are better than traditional drug courts at improving outcomes among people with opioid use disorder and connecting them to evidence-based treatment options with medication. 

Pre-trial diversion...immediate initiation on medication treatment for the criminal justice-involved. 

Continuum of Care
Treatment
Type of Evidence
Peer-reviewed
Replicated
Response Approach
Diversion
Medications for Opioid Use Disorder
Peer-reviewed Article

Evidence of Program Effectiveness

"After adjusting for current charge severity, gender, race/ethnicity, age, and county, OIC [opioid intervention court] participants were no more likely to initiate any SU [substance use] treatment but were significantly more likely to initiate MOUD (81.2% OIC vs 45.9% drug court, P < 0.001) and were more quickly linked to any SU treatment (hazard ratio = 1.68, 95% confidence interval = 1.35-2.08) and MOUD (hazard ratio = 4.25, 95% confidence interval = 3.23-5.58) after starting the court. Retention in court/MOUD was higher among drug court participants and may speak to the immediate sanctions (eg, jail) for noncompliance with drug court directives as compared with opioid court, which does not carry such immediate sanctions for noncompliance...These analyses suggest that the new OIC model can more rapidly link participants to treatment, including MOUD, as compared with traditional drug court model, and may demonstrate improved ability to immediately stabilize and reduce overdose risk in court participants." (Elkington et al., 2024)